iScience (Sep 2024)

SOX6 expression and aneurysms of the thoracic and abdominal aorta

  • David Carmona-Berrio,
  • Isabel Adarve-Rengifo,
  • Andrea G. Marshall,
  • Zer Vue,
  • Duane D. Hall,
  • Tyne W. Miller-Fleming,
  • Ky’Era V. Actkins,
  • Heather K. Beasley,
  • Paula M. Almonacid,
  • Pierina Barturen-Larrea,
  • Quinn S. Wells,
  • Marcos G. Lopez,
  • Edgar Garza-Lopez,
  • Dao-Fu Dai,
  • Jianqiang Shao,
  • Kit Neikirk,
  • Frederic T. Billings, IV,
  • John A. Curci,
  • Nancy J. Cox,
  • Vivian Gama,
  • Antentor Hinton, Jr.,
  • Jose A. Gomez

Journal volume & issue
Vol. 27, no. 9
p. 110436

Abstract

Read online

Summary: Abdominal and thoracic aortic aneurysms (AAAs, TAAs) remain a major cause of deaths worldwide, in part due to the lack of reliable prognostic markers or early warning signs. Sox6 has been found to regulate renin controlling blood pressure. We hypothesized that Sox6 may serve as an important regulator of the mechanisms contributing to hypertension-induced aortic aneurysms. Phenotype and laboratory-wide association scans in a clinical cohort found that SOX6 gene expression is associated with aortic aneurysm in subjects of European ancestry. Sox6 and tumor necrosis factor alpha (TNF-α) expression were upregulated in aortic tissues from patients affected by either AAA or TAA. In Sox6 knockout mice with angiotensin-II-induced AAA, we found that Sox6 plays critical role in the development and progression of AAA. Our data support a regulatory role of SOX6 in the development of hypertension-induced AAA, suggesting that Sox6 may be a therapeutic target for the treatment of aortic aneurysms.

Keywords